Jaime A Mejia
4PUBLICATIONS
53CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Dec 17, 2025
KEYLYNK-009: Pembrolizumab plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer after Clinical Benefit from First-Line Pembrolizumab plus Chemotherapy.Hope S Rugo, David W Cescon, Mark E Robson
|Nov 04, 2025
Factors influencing Patient Preferences for BRCA Testing and Adjuvant Therapy in HER2-Negative Early Breast Cancer in the United States: Best-Worst Scaling and Discrete Choice Experiment.Kathryn Mishkin, Qixin Li, Jagadeswara Rao Earla
|Jul 25, 2022
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.Kai Sun, Yitian Xu, Licheng Zhang
|Mar 21, 2018
An Isolated TCR αβ Restricted by HLA-A*02:01/CT37 Peptide Redirecting CD8+ T Cells To Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines.Pedro O Flores-Villanueva, Malathesha Ganachari, Heinner Guio
Pageof 1
Frequent Collaborators
1 joint publications
Pedro O Flores-Villanueva
1 joint publications
Malathesha Ganachari
1 joint publications
Kai Sun
1 joint publications
Yitian Xu
1 joint publications
Licheng Zhang
1 joint publications
Polly Niravath
1 joint publications
Jorge Darcourt
1 joint publications
Tejal Patel
1 joint publications
Bin S Teh
1 joint publications
Andrew M Farach
